04:51 PM EST, 02/20/2025 (MT Newswires) -- Globus Medical ( GMED ) reported Q4 non-GAAP earnings late Thursday of $0.84 per diluted share, up from $0.60 a year earlier.

Analysts polled by FactSet, on average, expected $0.75.

Net sales for the quarter ended Dec. 31 were $657.3 million, up from $616.5 million a year earlier.

Analysts expected $645.7 million.

For 2025, the company reaffirmed its prior outlook expecting non-GAAP EPS of $3.40 to $3.50 on $2.66 billion to $2.69 billion in revenue.

Analysts are looking for $3.44 and $2.67 billion, respectively.

Shares of Globus Medical ( GMED ) were up nearly 1% in Thursday's after-hours session.